Role of immunohistochemical detection of lymph-node metastases in management of breast cancer

Lancet

Volumn 354, Issue 9182, 1999, Pages 896-900

  Cote, R J ^a   Peterson, H F ^b   Chaiwun, B ^a   Gelber, R D ^b   Goldhirsch, A ^c   Castiglione Gertsch, M ^e   Gusterson, B ^d   Neville, A M ^f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b International Breast Cancer Study Group Statistical Center   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e Intl Breast Cancer Stud Grp C   (Switzerland)

^f LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYCLOPHOSPHAMIDE; CYTOKERATIN; EOSIN; ESTROGEN RECEPTOR; FLUOROURACIL; HEMATOXYLIN; METHOTREXATE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; STAINING; STATISTICAL ANALYSIS; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0033546902     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)11104-2     Document Type: Article

References (21)

1. Fisher B., Bauer M., Wickerham L., Redmond C.K., Fisher E.R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer. 52:1983;1551-1557.
2. Saez R.A., McGuire W.L., Clark C.M. Prognostic factors in breast cancer. Semin Surg Oncol. 5:1989;102-110.
3. Prolonged disease free survival after one course of perioperative adjuvant chemotherapy for node negative breast cancer. N Engl J Med. 320:1989;461-496.
4. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 335:1990;1565-1568.
5. Shi S-R., Cote R.J., Taylor C.R. Antigen retrieval immunohistochemistry: past, present and future. J Histochem Cytochem. 45:1997;327-343.
6. Veronesi U., Paganelli G., Galimberti V. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349:1997;1864-1867.
7. Saphir O., Amromin G.D. Obscure axillary lymph-node metastases in carcinoma of the breast. Cancer. 1:1948;238-241.
8. Hainsworth P.J., Tjandra J.J., Stillwell R.G.et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 80:1993;459-463.
9. Sedmak D.D., Meineke T.A., Knechtges D.S., Anderson J. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol. 2:1989;516-520.
10. Trojani M., de Mascarel I., Bonichon F., Coindre J.M., Delsol G. Micrometastases to axillary lymph nodes for carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 55:1987;303-306.
11. Nasser I.A., Lee A.K., Bosari S.et al. Occult axillary lymph node metastases in 'node-negative' breast carcinoma. Hum Pathol. 24:1993;950-957.
12. Goldhirsch A., Gelber R.D., Castiglione M.et al. Present and future projects of the International Breast Cancer Study Group. Cancer. 74:1994;1139-1149.
13. Cochran A.J., Wen D-R., Morton D.L. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: an immunohistochemical study. Am J Surg Pathol. 12:1988;612-618.
14. Liefers G-J., Cleton-Jansen A-M., Cornelis J.H.et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 339:1998;223-228.
15. Passlick B., Izbicki J.R., Kubuschok B.et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol. 12:1994;1827-1832.
16. Izbicki J.R., Hosch S.B., Pichlmeier U.et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 337:1997;1188-1194.
17. Nixon A.J., Neuberg D., Hayes D.F.et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 12:1994;888-894.
18. Redding W.H., Coombes R.C., Monaghan P.et al. Detection of micrometastases in patients with primary breast cancer. Lancet. ii:1983;1271-1274.
19. Cote R.J., Rosen P.P., Lesser M.L., Old L.J., Osborne M.P. Prediction of early relapse in patient with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol. 9:1991;1749-1756.
20. Dearnaley D.P., Ormerod M.G., Sloane J.P. Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer. 27:1991;236-239.
21. Diel I.J., Kaufmann M., Costa S.D.et al. Micrometastatic breast cancer cells in bone marrow at primary surgery - prognostic value in comparison to nodal status. J Natl Cancer Inst. 88:1996;1652-1658.